These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38550041)

  • 1. Retracted: Overexpression of 14-3-3
    International BR
    Biomed Res Int; 2024; 2024():9859520. PubMed ID: 38550041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of 14-3-3
    Wu Q; Fan H; Lang R; Li X; Zhang X; Lv S; He Q
    Biomed Res Int; 2020; 2020():8435420. PubMed ID: 32685532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Evaluation of Angiogenesis and Pathological Classification of Extrahepatic Cholangiocarcinoma by Dynamic MR Imaging for E-Healthcare.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9789030. PubMed ID: 37946889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
    Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
    Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Overexpression of 14-3-3
    International BR
    Biomed Res Int; 2024; 2024():9793464. PubMed ID: 38550083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retracted] Alteration of p53-binding protein 1 expression as a risk factor for local recurrence in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T; Shirai Y; Sakata J; Korita PV; Matsuda Y; Takamura M; Ohashi R; Nagahashi M; Ajioka Y; Hatakeyama K
    Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34468008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9834798. PubMed ID: 37387978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: High SIRPA Expression Predicts Poor Prognosis and Correlates with Immune Infiltrates in Patients with Esophageal Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9758202. PubMed ID: 37860319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Effect of Endoscopic Retrograde Cholangiopancreatography Lithotomy Combined with Laparoscopic Cholecystectomy on Pain and Prognosis of Patients with Gallstones and Extrahepatic Bile Duct Stones.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9841717. PubMed ID: 38074390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Complete Loss of Tyrosine Kinase Receptors MET and RON Is a Poor Prognostic Factor in Patients with Extrahepatic Cholangiocarcinoma.
    Hayashi Y; Yamaguchi J; Kokuryo T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Nagino M
    Anticancer Res; 2016 Dec; 36(12):6585-6592. PubMed ID: 27919987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer.
    Markers D
    Dis Markers; 2023; 2023():9898020. PubMed ID: 37502572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of laminin γ2 correlates with poor prognosis and promotes invasion in extrahepatic cholangiocarcinoma.
    Liu W; Tian F; Jiang P; Zhao X; Guo F; Li X; Wang S
    J Surg Res; 2014 Jan; 186(1):150-6. PubMed ID: 24124977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9807106. PubMed ID: 38094830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Application Value of Contrast-Enhanced Ultrasound Combined with Enhanced MR Scanning in Patients with Intrahepatic Cholangiocarcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9876728. PubMed ID: 37476736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9761231. PubMed ID: 37388089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9878451. PubMed ID: 38230158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9856509. PubMed ID: 37810558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.
    Markers D
    Dis Markers; 2023; 2023():9801930. PubMed ID: 37476642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: EF-Hand Domain-Containing Protein D2 (EFHD2) Correlates with Immune Infiltration and Predicts the Prognosis of Patients: A Pan-Cancer Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9805423. PubMed ID: 38094371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.